KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Short term Debt (2018 - 2026)

Takeda Pharmaceutical has reported Short term Debt over the past 9 years, most recently at $27.9 billion for Q1 2026.

  • For Q1 2026, Short term Debt rose 7.18% year-over-year to $27.9 billion; the TTM value through Mar 2026 reached $27.9 billion, up 7.18%, while the annual FY2026 figure was $29.0 billion, 11.48% up from the prior year.
  • Short term Debt was $27.9 billion for Q1 2026 at Takeda Pharmaceutical, up from $26.0 billion in the prior quarter.
  • Across five years, Short term Debt topped out at $27.9 billion in Q1 2026 and bottomed at $967.8 million in Q1 2024.
  • The 5-year median for Short term Debt is $2.6 billion (2023), against an average of $11.8 billion.
  • Year-over-year, Short term Debt plummeted 62.3% in 2024 and then soared 2586.33% in 2025.
  • Over 5 years, Short term Debt stood at $1.7 billion in 2022, then surged by 52.17% to $2.6 billion in 2023, then plummeted by 62.3% to $967.8 million in 2024, then surged by 2586.33% to $26.0 billion in 2025, then grew by 7.18% to $27.9 billion in 2026.
  • The last three reported values for Short term Debt were $27.9 billion (Q1 2026), $26.0 billion (Q1 2025), and $967.8 million (Q1 2024) per Business Quant data.